Talkspace (TALK) Competitors $2.64 +0.03 (+1.15%) Closing price 04:00 PM EasternExtended Trading$2.64 +0.00 (+0.08%) As of 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TALK vs. VRDN, PACS, GRAL, TDOC, OMDA, AHCO, NAKA, FTRE, PNTG, and CDNAShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include Viridian Therapeutics (VRDN), PACS Group (PACS), GRAIL (GRAL), Teladoc Health (TDOC), Omada Health (OMDA), AdaptHealth (AHCO), KindlyMD (NAKA), Fortrea (FTRE), The Pennant Group (PNTG), and CareDx (CDNA). These companies are all part of the "healthcare" industry. Talkspace vs. Its Competitors Viridian Therapeutics PACS Group GRAIL Teladoc Health Omada Health AdaptHealth KindlyMD Fortrea The Pennant Group CareDx Talkspace (NASDAQ:TALK) and Viridian Therapeutics (NASDAQ:VRDN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk. Does the media prefer TALK or VRDN? In the previous week, Viridian Therapeutics had 1 more articles in the media than Talkspace. MarketBeat recorded 2 mentions for Viridian Therapeutics and 1 mentions for Talkspace. Talkspace's average media sentiment score of 1.47 beat Viridian Therapeutics' score of 0.75 indicating that Talkspace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talkspace 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Viridian Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is TALK or VRDN more profitable? Talkspace has a net margin of 1.41% compared to Viridian Therapeutics' net margin of -112,806.88%. Talkspace's return on equity of 2.48% beat Viridian Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Talkspace1.41% 2.48% 2.11% Viridian Therapeutics -112,806.88%-78.95%-49.91% Which has preferable earnings and valuation, TALK or VRDN? Talkspace has higher revenue and earnings than Viridian Therapeutics. Viridian Therapeutics is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalkspace$187.59M2.36$1.15M$0.02132.00Viridian Therapeutics$300K5,324.88-$269.95M-$3.83-5.11 Do analysts prefer TALK or VRDN? Talkspace presently has a consensus price target of $4.50, suggesting a potential upside of 70.45%. Viridian Therapeutics has a consensus price target of $37.78, suggesting a potential upside of 93.14%. Given Viridian Therapeutics' higher possible upside, analysts plainly believe Viridian Therapeutics is more favorable than Talkspace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00Viridian Therapeutics 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90 Which has more volatility and risk, TALK or VRDN? Talkspace has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Viridian Therapeutics has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500. Do insiders and institutionals hold more shares of TALK or VRDN? 57.4% of Talkspace shares are owned by institutional investors. 23.5% of Talkspace shares are owned by insiders. Comparatively, 0.7% of Viridian Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryTalkspace beats Viridian Therapeutics on 13 of the 17 factors compared between the two stocks. Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$442.12M$2.13B$5.73B$10.43BDividend YieldN/AN/A5.61%4.58%P/E Ratio132.0736.1976.4226.62Price / Sales2.3610.82551.00126.98Price / Cash215.4759.0125.8131.15Price / Book3.8311.9713.626.47Net Income$1.15M-$63.46M$3.29B$271.57M7 Day Performance6.02%4.65%1.67%2.83%1 Month Performance-5.71%1.59%4.04%7.27%1 Year Performance30.05%40.92%80.70%26.07% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace4.1041 of 5 stars$2.64+1.1%$4.50+70.5%+19.2%$442.12M$187.59M132.07500VRDNViridian Therapeutics1.7781 of 5 stars$18.01-4.6%$37.78+109.8%-12.3%$1.54B$300K-4.7050PACSPACS Group3.0024 of 5 stars$10.41+6.8%$31.00+197.8%-67.3%$1.49B$3.11B0.0032,433Upcoming EarningsHigh Trading VolumeGRALGRAIL0.5081 of 5 stars$39.33+3.4%$31.50-19.9%+218.9%$1.37B$125.60M-3.001,360Gap UpTDOCTeladoc Health2.1016 of 5 stars$7.67-0.2%$9.80+27.8%-6.2%$1.36B$2.57B-6.445,500Options VolumeOMDAOmada HealthN/A$22.14+0.8%$24.50+10.7%N/A$1.26BN/A0.00849AHCOAdaptHealth3.912 of 5 stars$9.11-1.9%$13.40+47.1%-21.3%$1.26B$3.26B16.8710,500News CoveragePositive NewsNAKAKindlyMD2.4915 of 5 stars$1.24-55.4%$8.00+545.2%N/A$1.05B$2.72M-1.44N/AGap DownHigh Trading VolumeFTREFortrea3.7687 of 5 stars$10.20+1.0%$11.50+12.7%-59.7%$917.08M$2.73B-0.9015,500PNTGThe Pennant Group4.1929 of 5 stars$25.20-1.5%$34.40+36.5%-31.1%$884.10M$695.24M32.317,000CDNACareDx4.0921 of 5 stars$14.02+3.6%$25.50+81.9%-49.4%$720.16M$333.79M13.75740Analyst Forecast Related Companies and Tools Related Companies Viridian Therapeutics Competitors PACS Group Competitors GRAIL Competitors Teladoc Health Competitors Omada Health Competitors AdaptHealth Competitors KindlyMD Competitors Fortrea Competitors The Pennant Group Competitors CareDx Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TALK) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TALK Stock Alerts